What is the rationale for administering a 28‑day course of zinc supplementation to preterm infants?

Rationale for 28-Day Zinc Supplementation in Preterm Infants

Preterm infants require zinc supplementation for approximately 28 days (or longer) because they are born with critically low zinc stores, experience rapid postnatal growth that depletes these stores quickly, and face increased zinc losses through urine and stool—making them highly vulnerable to zinc deficiency that can impair growth, immune function, and increase mortality risk.

Why Preterm Infants Need Zinc Supplementation

Critical Zinc Deficit at Birth

Preterm infants miss the critical third trimester when most zinc accumulation occurs in utero. They need 400-500 mcg/kg/day to match the in-utero accretion rate 1—substantially higher than term infants who only require 250 mcg/kg/day 1. Standard trace element preparations don't supply this amount, necessitating additional supplementation 1.

Rapid Growth Demands

Zinc is essential for:

• Energy, protein, carbohydrate, lipid, and nucleic acid metabolism
• Tissue accretion and cell differentiation
• Over 70-120 metalloenzymes including carbonic anhydrase, alkaline phosphatase, and DNA/RNA polymerase 1, 2

The rapid postnatal growth of preterm infants creates enormous zinc demands that cannot be met by their limited stores 1.

Increased Zinc Losses

Preterm infants experience pathological zinc losses through:

• Urinary excretion: Amino acids in parenteral nutrition (histidine, threonine, lysine) bind zinc and increase renal ultra-filterability 1
• Gastrointestinal losses: Particularly with diarrhea, stoma output, or increased enteral fluid losses 1

Clinical Consequences of Zinc Deficiency

Zinc deficiency in preterm infants manifests as 1:

• Stunted growth and growth retardation
• Increased risk of infections (impaired immunity)
• Characteristic skin rash (parakeratosis)
• Diarrhea, apathy, and depression
• At severe levels: dermatitis followed by alopecia

Evidence for Duration and Efficacy

Mortality Benefit

Enteral zinc supplementation may moderately decrease all-cause mortality (RR 0.55,95% CI 0.31-0.97) 3. A 2024 study in very low birth weight infants showed reduced necrotizing enterocolitis (1% vs 11.2%, p=0.003) and fewer late-onset sepsis episodes with high-dose supplementation 4.

Growth Benefits

The evidence shows zinc supplementation:

• Probably improves weight gain (SMD 0.46,95% CI 0.28-0.64; moderate-certainty evidence) 3
• May slightly improve linear growth (SMD 0.75,95% CI 0.36-1.14) 3
• Increases weight by 378.57g (95% CI 275.26-481.88) and length by 2.92cm (95% CI 1.53-4.31) 5

Morbidity Reduction

• Decreases diarrhea (RR 0.81,95% CI 0.68-0.97) 5
• Reduces feeding intolerance (47.4% vs 65.3%, p=0.012) 4
• May reduce clinical sepsis episodes 4

Why 28 Days Specifically?

The 28-day duration represents:

1. The critical early postnatal period when zinc stores are most depleted and growth velocity is highest
2. Time to establish adequate enteral feeding and transition from parenteral to enteral nutrition
3. Duration needed to demonstrate measurable clinical benefits in research trials 3, 5, 6

However, supplementation should continue beyond 28 days if the infant remains hospitalized or has ongoing risk factors (high GI losses, inadequate enteral intake) 1. The 2018 ESPGHAN/ESPEN guidelines recommend ongoing supplementation at 400-500 mcg/kg/day for preterm infants until they transition to adequate enteral nutrition 1.

Practical Dosing Algorithm

For preterm infants (<37 weeks gestation or <2500g):

• Parenteral nutrition: 400-500 mcg/kg/day 1, 2
• Enteral supplementation: 300 mcg/kg/day for premature infants <1500g 2; 2-3 mg/kg/day has been used safely in trials 6, 4
• Duration: Minimum 28 days, continue until discharge or adequate enteral nutrition established
• Monitoring: Periodic serum zinc and alkaline phosphatase levels, especially with high GI losses 1

Important Caveats

• Breast milk zinc concentration declines rapidly after birth, making supplementation even more critical for breastfed preterm infants 7
• Higher doses (9-12 mg/day total) appear safe and may provide additional benefits for very low birth weight infants 4
• No serious adverse events reported with appropriate dosing 3, 5, 4
• Monitor copper status with prolonged high-dose zinc supplementation, though copper deficiency was not observed in recent studies 8

The 28-day timeframe is a minimum evidence-based duration that addresses the critical early postnatal period, but individualized continuation based on clinical status and feeding tolerance is appropriate.